A biotech startups lofty goal Kill cancer with pills that target RNA instead of proteins

A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins

Arrakis has identified “hits” — oral drug-like compounds — that block the RNA machinery needed to make some well-known, cancer-causing proteins.

More From BioPortfolio on "A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins"